These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 18420481

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Screening for familial intracranial aneurysms: decision and cost-effectiveness analysis.
    Takao H, Nojo T, Ohtomo K.
    Acad Radiol; 2008 Apr; 15(4):462-71. PubMed ID: 18342771
    [Abstract] [Full Text] [Related]

  • 5. Cost-effectiveness of preventive treatment of intracranial aneurysms: new data and uncertainties.
    Greving JP, Rinkel GJ, Buskens E, Algra A.
    Neurology; 2009 Jul 28; 73(4):258-65. PubMed ID: 19299311
    [Abstract] [Full Text] [Related]

  • 6. Risks and benefits of screening for intracranial aneurysms in first-degree relatives of patients with sporadic subarachnoid hemorrhage.
    Magnetic Resonance Angiography in Relatives of Patients with Subarachnoid Hemorrhage Study Group.
    N Engl J Med; 1999 Oct 28; 341(18):1344-50. PubMed ID: 10536126
    [Abstract] [Full Text] [Related]

  • 7. Do intraindividual variation in disease progression and the ensuing tight window of opportunity affect estimation of screening benefits?
    Koffijberg H, Rinkel G, Buskens E.
    Med Decis Making; 2009 Oct 28; 29(1):82-90. PubMed ID: 19147834
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Benefit, risks and cost-effectiveness of screening for abdominal aortic aneurysm.
    Schmidt T, Mühlberger N, Chemelli-Steingruber IE, Strasak A, Kofler B, Chemelli A, Siebert U.
    Rofo; 2010 Jul 28; 182(7):573-80. PubMed ID: 20563953
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cost-effectiveness analysis of screening for asymptomatic, unruptured intracranial aneurysms. A mathematical model.
    Yoshimoto Y, Wakai S.
    Stroke; 1999 Aug 28; 30(8):1621-7. PubMed ID: 10436111
    [Abstract] [Full Text] [Related]

  • 13. Cost-effective screening for cerebral aneurysms.
    Alterman RL, Drucker E.
    Neurosurg Clin N Am; 1998 Jul 28; 9(3):497-507. PubMed ID: 9668182
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Cost-effectiveness of treatment of unruptured intracranial aneurysms in patients with a history of subarachnoid hemorrhage.
    Takao H, Nojo T, Ohtomo K.
    Acad Radiol; 2008 Sep 28; 15(9):1126-32. PubMed ID: 18692753
    [Abstract] [Full Text] [Related]

  • 16. [Cigarette smoking increases the risk of developing a cerebral aneurysm and of subarachnoid hemorrhage].
    Matsumoto K, Akagi K, Abekura M, Ohkawa M, Tasaki O, Oshino S.
    No Shinkei Geka; 1999 Sep 28; 27(9):831-5. PubMed ID: 10478344
    [Abstract] [Full Text] [Related]

  • 17. [Screening for aneurysms in risk groups: meaningful?].
    Struffert T, Reith W.
    Radiologe; 2002 Nov 28; 42(11):880-4. PubMed ID: 12458440
    [Abstract] [Full Text] [Related]

  • 18. Cost and outcomes analysis.
    King JT, Ratcheson RA.
    Neurosurg Clin N Am; 1998 Jul 28; 9(3):629-40. PubMed ID: 9668193
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Cost-effectiveness of diagnostic strategies for evaluation of suspected subarachnoid hemorrhage in the emergency department.
    Ward MJ, Bonomo JB, Adeoye O, Raja AS, Pines JM.
    Acad Emerg Med; 2012 Oct 28; 19(10):1134-44. PubMed ID: 23067018
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.